A preliminary investigation into the practicality of use and duration of action of slow-release preparations of morphine and hydromorphone in laboratory rats

Laboratory Animals

Volumn 44, Issue 1, 2010, Pages 59-65

  Leach, M C ^a   Bailey, H E ^a   Dickinson, A L ^a   Roughan, J V ^a   Flecknell, P A ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Analgesia; Hargreaves assay; Hydromorphone; Morphine; Oral; Rat

Indexed keywords

HYDROMORPHONE; MORPHINE SULFATE;

ANALGESIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; DRUG FORMULATION; DRUG RELEASE; EXPERIMENTAL RAT; FEMALE; LATENT PERIOD; MALE; NOCICEPTION; NONHUMAN; PAIN THRESHOLD; RAT; THERMAL EXPOSURE;

ANALGESIA; ANALGESICS, OPIOID; ANIMALS; DELAYED-ACTION PREPARATIONS; FEMALE; HOT TEMPERATURE; HYDROMORPHONE; MALE; PAIN MEASUREMENT; PAIN THRESHOLD; PILOT PROJECTS; RATS; RATS, WISTAR; REACTION TIME; TIME FACTORS; VETERINARY MEDICINE;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 75449100103     PISSN: 00236772     EISSN: None     Source Type: Journal    
DOI: 10.1258/la.2009.007160     Document Type: Article

References (28)

1. Russell WMS, Burch RL, eds. The Principles of Humane Experimental Technique. 2nd edn. Wheathampstread: Universities Federation for Animal Welfare, 1959
2. Flecknell PA. The relief of pain in laboratory animals. Lab Anim 1984;18:147-60
3. Peckham EM, Traynor JR. Comparison of the antinociceptive responses to morphine and morphine-like compounds in male and female Sprague-Dawley rats. J Pharmacol Exp Ther 2006;316:1195-201
4. Flecknell PA, Waterman-Pearson A, eds. Pain Management in Animals. 1st edn. London: WB Saunders, 2000
5. Smith LJ, Valenzuela JR, Kruger-Higby LA, Brown C, Heath TD. A single dose of liposome-encapsulated hydromorphone provides extended analgesia in a rat model of neuropathic pain. Comp Med 2006;56:487-92
6. Wegner K, Robertson SA. Dose-related thermal antinociceptive effects of intravenous hydromorphone in cats. Vet Anesth and Analg 2007;34:132-8
7. Napp Pharmaceuticals Ltd. Product Characteristics for PALLADONE-SR® & MST-CONTINUS®. http://www.napp.co.uk/products, 2007
8. Festing MFW. Use of a multistrain assay could improve the NTP carcinogenesis bioassay. Environ Health Perspect 1995;103:44-52
9. FELASA. Recommendations for the health monitoring of mouse, rat, hamster, guineapig and rabbit breeding colonies. Lab Anim 2002;36:20-42
10. Hawkins P, Playle L, Golledge H, et al. Report: Newcastle Consensus Meeting on Carbon Dioxide Euthanasia of Laboratory Animals. http://www.nc3rs.org.uk, 2006
11. Zheng M, McErlane KM, Ong MC. Identification and synthesis of norhydromorphone, and determination of antinociceptive activities in the rat formalin test. Life Sci 2004;75:3129-46
12. Anderson R, Saiers JH, Abram S, Schlicht C. Accuracy in equianalgesic dosing: conversion dilemmas. J Pain Symptom Manage 2001;21:397-406
13. Souter KJ, Fitzgibbon D. Equianalgesic dose guidelines for long-term opioid use: theoretical and practical considerations. Perioper Med Pain 2004;23:271-80
14. Hargreaves KM, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988;32:77-88
15. Bonnichsen M, Dragsted N, Hansen AK. The welfare impact of gavaging laboratory rats. Anim Welf 2005;14:223-7
16. Morgan MM, Fossum EN, Stalding BM, King MM. Morphine antinociceptive potency on chemical, mechanical, and thermal nociceptive tests in the rat. J Pain 2005;7:358-66
17. Besson JM. The neurobiology of pain. Lancet 1999;353:1610- 15
18. Wheeler-Aceto H, Cowan A. Buprenorphine and morphine cause an antinociception by different transduction mechanisms. Eur J Pharmacol 1999;195:411-13
19. Girard P, Pansart Y, Gillerdin JM. Nefopam potentiates morphine antinociception in allodynia and hyperalgesia in the rat. Pharmacol Biochem Behav 2004;77:695-703
20. Roughan JV, Flecknell PA. Buprenorphine: a reappraisal of its antinociceptive effects and therapeutic use in alleviating postoperative pain in animals. Lab Anim 2002;36:322-43
21. Reichert JA, Daughters RS, Rivard R, Simone DA. Peripheral and preemptive opioid antinociception in a mouse visceral pain model. Pain 2001;89:221-7
22. Le Bars D, Gozariu M, Cadden SW. Animal models of nociception. Pharmacol Rev 2001;53:597-652
23. Petersen JS, Shalmi M, Christensen S, Haugan K, Lomholt N. Comparison of the renal effects of six sedating agents in rats. Physiol Behav 1996;60:759-65
24. Leach MC, Roughan JV, Dickinson A, Flecknell PA. Does sedation affect responses to antinociceptive tests in laboratory rats?Unpublished data, 2008
25. Wegner K, Horias KA, Tozier NA, Rathburn ML, Shtaerman Y, Yaksh TL. Development of a canine nociceptive thermal escape model. J Neurosci Methods 2007;168:88-97
26. Slingsby LS, Taylor PM. Thermal antinociception after dexmedetomidine administration in cats: a dose-finding study. J Vet Pharmacol Ther 2008;31:135-42
27. Perry RL, Carrig CB, Williams JF, Johnson CA, Kaneene JB. Anatomic features and radiographic observations of gastric emptying and small intestinal motility in the rat. Lab Anim Sci 1993;43:586-93
28. Kurz A, Sessler DI. Opioid-induced bowel dysfunction: pathophysiology and potential new therapies. Drugs 2003;63:649-71